These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21280068)

  • 1. The death panel for Charcot-Marie-Tooth panels.
    Amato AA; Reilly MM
    Ann Neurol; 2011 Jan; 69(1):1-4. PubMed ID: 21280068
    [No Abstract]   [Full Text] [Related]  

  • 2. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations.
    Zhu D; Kennerson ML; Walizada G; Züchner S; Vance JM; Nicholson GA
    Neurology; 2005 Aug; 65(3):496-7. PubMed ID: 16087932
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation screening of Charcot-Marie-Tooth patients in Poland.
    Kochański A; Timmerman V; Jedrzejowska H; Ryniewicz B; Löfgren A; De Vriendt E; Van Broeckhoven C; Latos-Bieleńska A; Hausmanowa-Petrusewicz I
    Ann N Y Acad Sci; 1999 Sep; 883():493-6. PubMed ID: 10586282
    [No Abstract]   [Full Text] [Related]  

  • 4. Axonal Charcot-Marie-Tooth disease: the fog is slowly lifting!
    Reilly MM
    Neurology; 2005 Jul; 65(2):186-7. PubMed ID: 16043782
    [No Abstract]   [Full Text] [Related]  

  • 5. The shifting landscape of genetic testing for Charcot-Marie-Tooth disease.
    England JD
    Muscle Nerve; 2014 Apr; 49(4):467-8. PubMed ID: 24006101
    [No Abstract]   [Full Text] [Related]  

  • 6. HMSN and HNPP. Laboratory service provision in the south west of England--two years' experience.
    Williams MM; Tyfield LA; Jardine P; Lunt PW; Stevens DL; Turnpenny PD
    Ann N Y Acad Sci; 1999 Sep; 883():500-3. PubMed ID: 10586284
    [No Abstract]   [Full Text] [Related]  

  • 7. Some considerations on atypical cases of Charcot-Marie-Tooth disease and use of genetic testing in idiopathic polyneuropathies.
    Mondelli M; Fabrizi GM
    Clin Neurol Neurosurg; 2010 Nov; 112(9):745-6. PubMed ID: 20800965
    [No Abstract]   [Full Text] [Related]  

  • 8. Charcot-Marie-Tooth Disease Associated With a Novel Mutation in MFN2 Presenting With Subacute Vision Loss.
    Li Y; Aleman TS; Quinn CC; Xia T; Miller CG; Kim BJ; Tamhankar MA
    J Neuroophthalmol; 2022 Mar; 42(1):e381-e384. PubMed ID: 34924536
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing practices for Charcot-Marie-Tooth type 1A disease.
    Tousignant R; Trepanier A; Shy ME; Siskind CE
    Muscle Nerve; 2014 Apr; 49(4):478-82. PubMed ID: 23963961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2.
    McCorquodale DS; Montenegro G; Peguero A; Carlson N; Speziani F; Price J; Taylor SW; Melanson M; Vance JM; Züchner S
    J Neurol; 2011 Jul; 258(7):1234-9. PubMed ID: 21258814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutation of the mitofusin 2 gene in a family with Charcot-Marie-Tooth disease type 2.
    Bergamin G; Dalla Torre C; Cacciavillani M; Lucchetta M; Boaretto F; Campagnolo M; Mostacciuolo ML; Briani C
    Muscle Nerve; 2014 Jan; 49(1):145-6. PubMed ID: 23929728
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA
    Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population.
    Gess B; Schirmacher A; Boentert M; Young P
    Neuromuscul Disord; 2013 Aug; 23(8):647-51. PubMed ID: 23743332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot-Marie-Tooth disease: an update.
    Shy ME
    Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen-year longitudinal follow-up of a patient with severe early-onset Charcot-Marie-Tooth disease type 2A.
    McCray BA; Hurst W; Crawford TO; Lloyd TE
    Muscle Nerve; 2018 May; 57(5):E126-E128. PubMed ID: 29266326
    [No Abstract]   [Full Text] [Related]  

  • 17. A new gene for the Charcot-Marie-Tooth disorder.
    Ben-Asher E; Lancet D
    Isr Med Assoc J; 2004 Jun; 6(6):376-7. PubMed ID: 15214472
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial fusion protein mutated in CMT2A.
    Bradbury J
    Lancet Neurol; 2004 Jun; 3(6):326. PubMed ID: 15176403
    [No Abstract]   [Full Text] [Related]  

  • 19. MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2.
    Kawarai T; Yamasaki K; Mori A; Takamatsu N; Osaki Y; Banzrai C; Miyamoto R; Oki R; Pedace L; Orlacchio A; Nodera H; Hashiguchi A; Higuchi Y; Takashima H; Nishida Y; Izumi Y; Kaji R
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1263-1265. PubMed ID: 27154191
    [No Abstract]   [Full Text] [Related]  

  • 20. Semi-dominant mutations in MFN2-related neuropathy and implications for genetic counselling.
    Tomaselli PJ; Rossor AM; Polke JM; Poh R; Blake J; Reilly MM
    J Peripher Nerv Syst; 2016 Mar; 21(1):52-4. PubMed ID: 26930221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.